Wang Y, Shang J, Yu M, Liu G, Liu X, Wang F. A Label-Free Phosphate-Transfer DNAzyme for the Cost-Effective Point-of-Care Detection of Influenza Virus. Angew Chem Int Ed Engl. 2025 Dec 9:e16920
DNAzymes have significantly enriched the toolbox for point-of-care testing (POCT); however, their inferior biostability and reliance on costly chemical labeling limit their broader applicability in high-throughput viral sample analysis. Herein, we constructed a label-free DNAzyme POCT platform for the accurate detection of influenza virus, with low cost (approximately US$0.20 per test). The simple yet robust viral detection system consists merely of a phosphate-transferase-mimicking DNAzyme (P-Dz) with a newly discovered highly-efficient small-molecule substrate, 6,8-difluoro-4-methylumbelliferyl phosphate (DiFMUP). Target viral RNA could specifically restore the catalytically active conformation of P-Dz for initiating the phosphate transfer reaction from DiFMUP and for producing a high fluorescence signal. Without the prerequisite of laborious and expensive chemical labeling of DNA substrate, a readily accessible test filter strip (TFS) was introduced into the system, enabling the interpretation of fluorescence readout via smartphone visualization and thereby achieving the amplified detection of various viral RNA targets. This label-free DNAzyme platform provides a cost-effective and portable platform for bioanalysis, with considerable potential in epidemiological diagnostics and therapeutic monitoring.
See Also:
Latest articles in those days:
- Human monoclonal antibodies that target clade 2.3.4.4b H5N1 hemagglutinin 20 hours ago
- [preprint]Vaccine-induced antigenic drift of a human-origin H3N2 Influenza A virus in swine alters glycan binding and sialic acid avidity 2 days ago
- [preprint]High pathogenicity avian influenza virus H5N1 (clade 2.3.4.4b) drives mass mortality in Eurasian crane (Grus grus) populations in Germany, 2025 2 days ago
- Experimental infection of alpacas (Vicugna pacos) with influenza C or D viruses results in subclinical upper respiratory tract disease 2 days ago
- Extended influenza seasons in Australia and New Zealand in 2025 due to the emergence of influenza A(H3N2) subclade K viruses 3 days ago
[Go Top] [Close Window]


